Filtered By:
Condition: Renal Failure
Countries: Saudi Arabia Health

This page shows you your search results in order of date. This is page number 12.

Order by Relevance | Date

Total 187 results found since Jan 2013.

Clinicohistological Profile and Outcomes of Rapidly Progressive Glomerulonephritis: A Prospective Study from North India
This study included 40 patients of biopsy-proven RPGN. The diagnosis of RPGN was based on renal histology showing crescents in >50% of glomeruli. All patients were given induction with intravenous (IV) methylprednisolone (0.5 g) for three days followed by maintenance with oral prednisolone (1 mg/kg/day) and six IV pulses of cyclophosphamide (0.5 g) given fortnightly followed by maintenance therapy with azathioprine (2 mg/kg/day). The outcomes were recorded. Three-fourth of the patients (77.4%) required renal replacement therapy (RRT) at diagnosis. More than half of patients (57.5%) were antineutrophil cytoplasmic antibo...
Source: Saudi Journal of Kidney Diseases and Transplantation - January 17, 2023 Category: Urology & Nephrology Authors: Deepak Sharma Sudhir Mehta Jasvinder Singh Sandhu Preet Mohinder Sohal Vikas Makkar Source Type: research

The influence of the disclosure of diabetes on the cognitive, physical ability and diabetes self ‐management in diabetic employed adults in Saudi Arabia
ConclusionIt is essential for top management and policymakers to implement supportive programmes in the workplace, and considering a constant, not rotating, work schedule.
Source: Nursing Open - December 12, 2021 Category: Nursing Authors: Sitah Alshutwi, Eman Miligi, Lujain Alhumidan, Adel F. Almutairi Tags: RESEARCH ARTICLE Source Type: research

Prevalence of micro and macro vascular complications and their risk factors in type 2 diabetes in Saudi Arabian population: an analysis from SHIS
CONCLUSIONS: The high prevalence of microvascular and macrovascular complications in diabetic patients poses a serious threat to public health in Saudi Arabia. A multisectoral approach needs to be undertaken to properly control and modify common risk factors at the community level.PMID:34227065 | DOI:10.26355/eurrev_202106_26137
Source: European Review for Medical and Pharmacological Sciences - July 6, 2021 Category: Drugs & Pharmacology Authors: M S Ahmad T Alslamah S M Alannaz R A Shaik R K Ahmad M Yusuf M Khan A Ghimire Source Type: research